Alnylam Pharmaceuticals
ALNY
#559
Rank
C$61.47 B
Marketcap
C$463.55
Share price
-0.16%
Change (1 day)
29.94%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company